These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 21369712)

  • 61. Transfersomes: self-optimizing carriers for bioactives.
    Rai K; Gupta Y; Jain A; Jain SK
    PDA J Pharm Sci Technol; 2008; 62(5):362-79. PubMed ID: 19055232
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Modulated delivery of donepezil using a combination of skin microporation and iontophoresis.
    Kale M; Kipping T; Banga AK
    Int J Pharm; 2020 Nov; 589():119853. PubMed ID: 32898633
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Skin permeabilization for transdermal drug delivery: recent advances and future prospects.
    Schoellhammer CM; Blankschtein D; Langer R
    Expert Opin Drug Deliv; 2014 Mar; 11(3):393-407. PubMed ID: 24392787
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Passive delivery of protein drugs through transdermal route.
    Chaulagain B; Jain A; Tiwari A; Verma A; Jain SK
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):472-487. PubMed ID: 29378433
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recent Advances in Skin Penetration Enhancers for Transdermal Gene and Drug Delivery.
    Amjadi M; Mostaghaci B; Sitti M
    Curr Gene Ther; 2017; 17(2):139-146. PubMed ID: 28494734
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Iontophoretic drug delivery.
    Kalia YN; Naik A; Garrison J; Guy RH
    Adv Drug Deliv Rev; 2004 Mar; 56(5):619-58. PubMed ID: 15019750
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Recent developments in topical and transdermal delivery.
    Hadgraft J
    Eur J Drug Metab Pharmacokinet; 1996; 21(2):165-73. PubMed ID: 8839691
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Noninvasive approach for enhancing small interfering RNA delivery percutaneously.
    Aljuffali IA; Lin YK; Fang JY
    Expert Opin Drug Deliv; 2016; 13(2):265-80. PubMed ID: 26592090
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Skin permeation and transdermal delivery systems of drugs: history to overcome barrier function in the stratum corneum].
    Sugino M; Todo H; Sugibayashi K
    Yakugaku Zasshi; 2009 Dec; 129(12):1453-8. PubMed ID: 19952520
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Macromolecules as novel transdermal transport enhancers for skin electroporation.
    Vanbever R; Prausnitz MR; Préat V
    Pharm Res; 1997 May; 14(5):638-44. PubMed ID: 9165536
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Electronically facilitated transdermal delivery of human parathyroid hormone (1-34).
    Medi BM; Singh J
    Int J Pharm; 2003 Sep; 263(1-2):25-33. PubMed ID: 12954177
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Permeability enhancement for transdermal delivery of large molecule using low-frequency sonophoresis combined with microneedles.
    Han T; Das DB
    J Pharm Sci; 2013 Oct; 102(10):3614-22. PubMed ID: 23873449
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Transdermal innovations in diabetes management.
    Rao R; Mahant S; Chhabra L; Nanda S
    Curr Diabetes Rev; 2014; 10(6):343-59. PubMed ID: 25418713
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Topical delivery of active principles: the field of dermatological research.
    Nino M; Calabrò G; Santoianni P
    Dermatol Online J; 2010 Jan; 16(1):4. PubMed ID: 20137746
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Penetration enhancement of transdermal delivery--current permutations and limitations.
    Purdon CH; Azzi CG; Zhang J; Smith EW; Maibach HI
    Crit Rev Ther Drug Carrier Syst; 2004; 21(2):97-132. PubMed ID: 15202928
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ultrasound and transdermal drug delivery.
    Lavon I; Kost J
    Drug Discov Today; 2004 Aug; 9(15):670-6. PubMed ID: 15279850
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Transdermal drug delivery enhanced and controlled by erbium:YAG laser: a comparative study of lipophilic and hydrophilic drugs.
    Lee WR; Shen SC; Lai HH; Hu CH; Fang JY
    J Control Release; 2001 Jul; 75(1-2):155-66. PubMed ID: 11451505
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Electroporation as an efficient physical enhancer for skin drug delivery.
    Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Revilla-Vázquez AL
    J Clin Pharmacol; 2009 Nov; 49(11):1262-83. PubMed ID: 19717723
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Investigation into the potential of electroporation facilitated topical delivery of cyclosporin a.
    Liu HZ; Wang YJ; Xu L; Li SM
    PDA J Pharm Sci Technol; 2010; 64(3):191-9. PubMed ID: 21502019
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Reversible skin permeabilization for transdermal delivery of macromolecules.
    Prausnitz MR
    Crit Rev Ther Drug Carrier Syst; 1997; 14(4):455-83. PubMed ID: 9450177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.